Drug Quiz 2 Flashcards
(39 cards)
Albuterol Sulfate
Proventil HFA, ProAir HFA
Albuterol Sulfate Drug Classification
Sympathomimetic/Sympathetic agonist (b2 selective)
Albuterol Sulfate Mechanism of Action
B2 agonist->bronchodilation
Albuterol Sulfate Pharmacokinetics
Onset of Action=5-15 min
Peak effects=1-1.5 hours
Duration of effect=3-6 hours
Half-Life=< 3 hours
Albuterol Sulfate Indications/Field use
1) Asthma
2) Reversible bronchospasm associated with COPD
Albuterol Sulfate Contraindications
Symptomatic tachycardia, pts with a history of hypersensitivity to this drug
Albuterol Sulfate Side Effects/Adverse Reactions
Anxiety, HA, palpitations, sweating, dizziness, nervousness, tremor, HTN, arrhythmias, chest pain, N+V
Albuterol Sulfate Dose
MDI: (Adult) 1 or 2 sprays (90mg/spray)
Small-volume nebulizer: (Adult) 2.5mg in 2.5mL NS over 5-15min
Small-volume nebulizer: (Pedi) 2.5mg in 2.5mL NS over 5-15min
Albuterol Sulfate Precautions
1) BP, pulse, and EKG should be monitored
2) use caution with pts with known heart disease or HTN
3) auscultate LS before and after treatment
Albuterol Sulfate Drug-Drug Interactions
1) SE may increase with other sympathetic agonists
2) B blockers may blunt effects of this drug
3) MAOI and TCA may potentiate cardiovascular effects
Ipratroprium Bromide
Atrovent
Ipratroprium Bromide Drug Classification
Anticholinergic/Parasympathetic
Ipratroprium Bromide Mechanism of Action
Muscarinic ACh-R blocker->inhibits parasympathetic stimulation and vagally mediated responses by preventing increase in intracellular cGMP in bronchial smooth muscle->dries respiratory tract secretions and allows for bronchodilation
Ipratroprium Bromide Pharmacokinetics
Onset of Action=varies
Peak Effects=1.5-2hours
Duration of Effect=4-6hours
Half-Life=1.5-2hours
Ipratroprium Bromide Indications/Field use
1) Bronchial Asthma
2) Reversible bronchospasm associated with COPD
Ipratroprium Bromide Contraindications
1) pts with history of hypersensitivity?
2) should not be used as primary acute treatment of bronchospasm
Ipratroprium Bromide Side Effects/Adverse Reactions
Anxiety, HA, palpitations, dizziness, nervousness, rash, N+V
Ipratroprium Bromide Dose
Small-volume nebulizer: (Adult) 500mg-typically administered with a beta agonist
Small-volume nebulizer: (Pedi) 250-500mg q20min PRN
Also available as MDI
Ipratroprium Bromide Precautions
1) BP, pulse, and EKG should be monitored
2) use caution with pts with known heart disease or HTN and elderly
3) auscultate LS before and after treatment
Ipratroprium Bromide Drug-Drug Interactions
Few prehospitally, not specified
Magnesium Sulfate drug classification
Electrolyte/Antidysrhythmic/Mineral
Magnesium Sulfate Mechanism of Action
Psycologic Ca2+ channel blocker->blocks neuromuscular transmission, causes CNS depressants and smooth muscle relaxation
Magnesium Sulfate Pharmacokinetics
Onset of Action=Immediate IV, 1 hour IM
Peak Effects=Varies
Duration of Effect=1 hour
Half-Life=N/A
Magnesium Sulfate Indications/Field Use
1) Severe Asthma/ Bronchospasm
2) Severe refractory VF or pulseless VT with hypoMg2+ and Torsades de Pointes
3) Post-MI prophylaxis of dysrhythmias
4) Ecclampsia, Pre-Term Labor